is tirzepatide back on the shortage list FDA says this weight loss drug over, but patients worry about cost and availability FDA warns compounding pharmacies on

Semaglutide, a GLP-1 receptor agonist originally developed for type 2 diabetes, has emerged as a potential tool for reducing liver fat accumulation and improving liver function in patients with metabolic dysfunction

Your prescriber may also recommend an alternative if you have severe stomach or intestinal problems, pancreatitis, or other conditions that could make Mounjaro unsafe

Plus, its crucial to monitor your cardiovascular health while taking tirzepatide, as it may increase the risk of heart problems

In honor of Thyroid Cancer Awareness Month, host McCall McPherson welcomes Dr

In this section, we delve into the nuances, explore clinical guidelines, and provide insights from healthcare professionals to help clarify this topic

This open-label trial examined the effects of semaglutide in individuals with schizophrenia receiving either clozapine or olanzapine